pramipexole has been researched along with 6-methyl-2-(phenylethynyl)pyridine in 1 studies
Studies (pramipexole) | Trials (pramipexole) | Recent Studies (post-2010) (pramipexole) | Studies (6-methyl-2-(phenylethynyl)pyridine) | Trials (6-methyl-2-(phenylethynyl)pyridine) | Recent Studies (post-2010) (6-methyl-2-(phenylethynyl)pyridine) |
---|---|---|---|---|---|
1,103 | 219 | 517 | 543 | 0 | 185 |
Protein | Taxonomy | pramipexole (IC50) | 6-methyl-2-(phenylethynyl)pyridine (IC50) |
---|---|---|---|
Luciferin 4-monooxygenase | Photinus pyralis (common eastern firefly) | 6.2333 | |
Metabotropic glutamate receptor 5 | Rattus norvegicus (Norway rat) | 0.0129 | |
Metabotropic glutamate receptor 5 | Homo sapiens (human) | 0.0199 | |
Amine oxidase [flavin-containing] A | Mus musculus (house mouse) | 8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dardou, D; Durif, F; Fleurance, R; Gryshkova, V; Hafidi, A; Loiodice, S; McGhan, P; Nogueira da Costa, A | 1 |
1 other study(ies) available for pramipexole and 6-methyl-2-(phenylethynyl)pyridine
Article | Year |
---|---|
Striatal changes underlie MPEP-mediated suppression of the acquisition and expression of pramipexole-induced place preference in an alpha-synuclein rat model of Parkinson's disease.
Topics: alpha-Synuclein; Animals; Benzothiazoles; Corpus Striatum; Dopamine; Excitatory Amino Acid Antagonists; Impulsive Behavior; Male; Nucleus Accumbens; Parkinson Disease; Pramipexole; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Receptors, Glutamate; Up-Regulation | 2017 |